Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
For the full year,net profit declined 22.18% to Rs 43.08 crore in the year ended March 2026 as against Rs 55.36 crore during the previous year ended March 2025. Sales rose 6.89% to Rs 287.23 crore in the year ended March 2026 as against Rs 268.72 crore during the previous year ended March 2025.
Jagsonpal Pharmaceuticals has portfolio of drugs focusing on gynaecology, orthopaedics, dermatology and child-care segments.
The company’s standalone net profit fell 8.4% to Rs 12.49 crore on 1.5% fall in net sales to Rs 72.95 crore in Q3 FY26 compared with Q3 FY25.